Less is more: Abdominal closure protocol does not reduce surgical site infection after hysterectomy.


Journal

Gynecologic oncology
ISSN: 1095-6859
Titre abrégé: Gynecol Oncol
Pays: United States
ID NLM: 0365304

Informations de publication

Date de publication:
07 2022
Historique:
received: 28 02 2022
revised: 21 04 2022
accepted: 22 04 2022
pubmed: 8 5 2022
medline: 23 6 2022
entrez: 7 5 2022
Statut: ppublish

Résumé

To determine rates of surgical site infection (SSI) with and without an abdominal closure protocol for gynecologic oncology patients undergoing abdominal hysterectomy. Consecutive patients were identified using CPT codes who underwent total abdominal hysterectomy by gynecologic oncologists at a tertiary care center from January 1, 2015 to December 31, 2019, and stratified by use of the abdominal closure protocol. Demographic, perioperative, and pathologic variables were collected. Fisher's exact and Chi squared tests were used for categorical variables, logistic regression and student t-tests for continuous variables. Multiple logistic regression was used to analyze the relationships between these variables, use of the closure protocol, and development of SSI. 739 patients were included over the study period (n = 393 pre-implementation, n = 346 post-implementation of the abdominal closure protocol,). Baseline demographics including ASA score, BMI, diabetes, and smoking were similar between these groups (P = 0.14-0.94). The rate of SSI within 30 days was 5.9% (23/393) in the pre-protocol group and 8.1% (28/346) under the abdominal closure protocol (P = 0.25). On univariate analysis, factors associated with SSI were BMI >40, diabetes, bowel resection, ASA score 3 or 4, hypertension, and contaminated wound class (uOR 2.31-4.09). On multivariate analysis BMI >40, diabetes, and bowel resection remained independent risk factors (aOR 2.27-2.99), with the closure protocol not achieving significance (aOR 1.43, 95% CI 0.79-2.59). There were no potentially high-risk sub-groups in whom the closing protocol showed benefit. The abdominal closure protocol in isolation did not decrease SSI in those undergoing TAH by a gynecologic oncologist.

Identifiants

pubmed: 35525601
pii: S0090-8258(22)00261-X
doi: 10.1016/j.ygyno.2022.04.020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-75

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None of the authors have any conflict of interest to disclose.

Auteurs

Joseph A DeMari (JA)

Division of Gynecologic Oncology, Wake Forest School of Medicine, Winston Salem, USA. Electronic address: jdemari@wakehealth.edu.

Glenn P Boyles (GP)

Department of Obstetrics and Gynecology, The Ohio State University, Columbus, USA.

David A Barrington (DA)

Division of Gynecologic Oncology, The Ohio State University, Columbus, USA.

B S Audrey Busho (BS)

College of Medicine, The Ohio State University, Columbus, USA.

B S Jae Baek (BS)

College of Medicine, The Ohio State University, Columbus, USA.

David E Cohn (DE)

Division of Gynecologic Oncology, The Ohio State University, Columbus, USA.

Christa I Nagel (CI)

Division of Gynecologic Oncology, The Ohio State University, Columbus, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH